Beovu Vision Problems May Be Linked To Delayed Hypersensitivity Reaction, Case Report Suggests
A case study warns Beovu vision loss may be linked to a delayed hypersensitivity reaction in certain patients.…
«
»
A case study warns Beovu vision loss may be linked to a delayed hypersensitivity reaction in certain patients.…
Novartis warns patients who recently experienced eye inflammation problems appear to face a higher risk of Beovu retinal vasculitis side effects.…
Shortly after introducing the wet-age related macular degeneration (AMD) treatment Beovu, side effects were linked to reports of severe and potentially blinding vision problems. As a result, new warnings about this risk were added in June 2020. STATUS OF BEOVU LAWSUITS: A limited group of users who received an injection for treatment of AMD between October 2019 and July 2020 may be entitled to financial compensation through a Beovu lawsuit. Lawyers are reviewing cases for users who experienced: Retinal Vasculitis Retinal Vascular Occlusion >CONTACT A BEOVU LAWYER ABOUT A CASE…
Novartis says that rates of eye inflammation and vision loss linked to Beovu are below those listed on the warning label.…
A group of retinal specialists warn that the eye treatment Beovu has been linked to cases of eye inflammation which could result in vision loss.…
Tasigna is a blockbuster cancer drug used to treat chronic myeloid leukemia (CML), which has been linked to serious side effects that can constrict and harden arteries, potentially increasing the risk of heart attack, stroke, amputation and sudden death. …
All generic Zantac manufactured and distributed by Sandoz has been recalled due to NDMA contamination.…
The heartburn drug Zantac is being pulled from the market after a pharmacy found that it contained large amounts of a likely cancer-causing impurity.…
The FDA says a Novartis subsidiary manipulated data in animal trials used to approve a gene therapy treatment for children, but will let the treatment, the most expensive in the world, stay on the market due to a lack of other treatment options.…
Novartis has filed a lawsuit against Johnson & Johnson claiming it is using misleading advertising to promote the psoriasis drug Tremfya, which omits critical safety data.…